A study on the expression of interleukin(IL)-10 and IL-12 P35, P40 mRNA in the psoriatic lesions
- 1 March 2001
- journal article
- Published by Springer Nature in Journal of Huazhong University of Science and Technology [Medical Sciences]
- Vol. 21 (1) , 86-88
- https://doi.org/10.1007/bf02888047
Abstract
To investigate the possible role of interleukin (IL)-10 and IL-12 in the pathogenesis of psoriatic lesions and to supply theoretical basis for the gene therapy for psoriasis, the expression of IL-10 and IL-12 P35, P40 mRNA in 12 cases of psoriatic lesions and 6 normal skin tissues was detected by using RT-PCR technique. The results showed that the expression of IL-10 mRNA in the psoriatic lesions was significantly lower than that in the normal skin tissues (P<0. 001). The expression of IL-12 P35 was positive both in the psoriatic lesions and in the normal skin tissues. IL-12 P40 mRNA was expressed positively only in the psoriatic lesions but negatively in the normal skin tissues. It was suggested that IL-12 might take an important role in the occurrence and progression of psoriasis, but IL-10 might have certain role in the regression of psoriasis.Keywords
This publication has 7 references indexed in Scilit:
- Expression of Interleukin-12 is Increased in Psoriatic SkinJournal of Investigative Dermatology, 1998
- IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.Journal of Clinical Investigation, 1998
- Interleukin‐10 inhibits IgE‐mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytesEuropean Journal of Immunology, 1995
- Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.The Journal of Immunology, 1995
- IL-10 inhibits cytokine production by activated macrophages.The Journal of Immunology, 1991
- The cytokine network in psoriasis.1991
- The Cytokine Network in PsoriasisArchives of Dermatology, 1991